Phase II Study of Digitoxin to Treat Cystic Fibrosis

NCT00782288 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: digitoxin
DRUG: digitoxin
OTHER: placebo

Sponsor

National Jewish Health